Faricimab: Transforming the Future of Macular Diseases Treatment - A Comprehensive Review of Clinical Studies

Faricimab: Transforming the Future of Macular Diseases Treatment - A Comprehensive Review of Clinical Studies

Georgios D Panos,1,2 Arun Lakshmanan,1 Panagiotis Dadoukis,3 Matteo Ripa,4 Lorenzo Motta,4 Winfried M Amoaku1,2 1Department of Ophthalmology, Queen’s Medical Centre, Nottingham University Hospitals, Nottingham, UK; 2Division of Ophthalmology and Visual Sciences, Faculty of Medicine & Health Scie...

Full description

Bibliographic Details
Main Authors:	Panos GD, Lakshmanan A, Dadoukis P, Ripa M, Motta L, Amoaku WM
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-09-01
Series:	Drug Design, Development and Therapy
Subjects:	degenerative macular disorders faricimab anti-vegf efficacy safety intravitreal treatment age-related macular degeneration diabetic macular oedema retinal vein occlusion diabetic retinopathy
Online Access:	https://www.dovepress.com/faricimab-transforming-the-future-of-macular-diseases-treatment---a-co-peer-reviewed-fulltext-article-DDDT

Similar Items

Efficacy, Durability and Safety of Faricimab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Oedema: Lessons Learned from Registration Trials
by: Helene O. Larsen, et al.
Published: (2023-07-01)

Faricimab for Treatment-Resistant Diabetic Macular Edema
by: Rush RB, et al.
Published: (2022-08-01)

Aflibercept versus Faricimab in the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Review
by: Sławomir Liberski, et al.
Published: (2022-08-01)

One Year Results of Faricimab for Aflibercept-Resistant Diabetic Macular Edema
by: Rush RB
Published: (2023-08-01)

Real-World Data on Faricimab Switching in Treatment-Refractory Neovascular Age-Related Macular Degeneration
by: Benjamin Ng, et al.
Published: (2024-01-01)

Review of real-world evidence of dual inhibition of VEGF-A and ANG-2 with faricimab in NAMD and DME
by: Fernando M Penha, et al.
Published: (2024-01-01)

Comparison of Loading Dose between Aflibercept and Faricimab for Neovascular Age-Related Macular Degeneration
by: Chikako Hara, et al.
Published: (2024-01-01)

Treatment of Macular Edema in Vascular Retinal Diseases: A 2021 Update
by: Andrzej Grzybowski, et al.
Published: (2021-11-01)

Anti-VEGF-Resistant Retinal Diseases: A Review of the Latest Treatment Options
by: Josh O. Wallsh, et al.
Published: (2021-04-01)

Rho-Kinase Inhibitors for the Treatment of Refractory Diabetic Macular Oedema
by: Milagros Mateos-Olivares, et al.
Published: (2021-07-01)

Research progress of novel bispecific monoclonal antibody Faricimab in the treatment of diabetic macular edema and age-related macular degeneration
by: Xin-Li Wei, et al.
Published: (2023-10-01)

One-year visual and anatomical outcomes of intravitreal faricimab injection for neovascular age-related macular degeneration after prior brolucizumab treatment
by: Hironori Takahashi, et al.
Published: (2024-04-01)

Intravitreal Faricimab for Aflibercept-Resistant Neovascular Age-Related Macular Degeneration
by: Rush RB, et al.
Published: (2022-12-01)

Brolucizumab for the Treatment of Degenerative Macular Conditions: A Review of Clinical Studies
by: Karasavvidou EM, et al.
Published: (2022-08-01)

Profile of Patients Treated with Intravitreal Anti-Vascular Endothelial Growth Factor Injections in Bhutan
by: Rai BB, et al.
Published: (2023-06-01)

Spotlight on Faricimab in the Treatment of Wet Age-Related Macular Degeneration: Design, Development and Place in Therapy
by: Nair AA, et al.
Published: (2022-09-01)

Bevacizumab therapy for macular edema in central retinal vein occlusion: Long-term results
by: George J Manayath, et al.
Published: (2009-01-01)

Farklı etyolojilere bağlı maküler ödem tedavisinde deksametazon implantın etkinliği
by: Emrah Öztürk, et al.
Published: (2020-06-01)

Intravitreal Fluocinolone Acetonide Implant (ILUVIEN®) for the Treatment of Retinal Conditions. A Review of Clinical Studies
by: Mushtaq Y, et al.
Published: (2023-03-01)

The Dilemma between the Randomized Control Trials and Real Life Practice in the Treatment of Retinal Diseases with Intravitreal anti-VEGF agents
by: Abdullah Özkaya, et al.
Published: (2017-05-01)

Efficacy of intravitreal Conbercept injection for macular edema secondary to macular branch retinal vein occlusion
by: Ping-Li Zhu, et al.
Published: (2018-01-01)

Visual and Anatomical Outcomes After Initial Intravitreal Faricimab Injection for Neovascular Age-Related Macular Degeneration in Patients with Prior Treatment History
by: Satoru Inoda, et al.
Published: (2023-08-01)

BALATON and COMINO: Phase III Randomized Clinical Trials of Faricimab for Retinal Vein Occlusion
by: Lars-Olof Hattenbach, MD, PhD, et al.
Published: (2023-09-01)

Study on the change of retinal thickness and choroidal thickness and correlative factors for macular edema after Ranibizumab injection
by: Guan-Lu Liang, et al.
Published: (2018-05-01)

Short-Term Outcomes of Intravitreal Faricimab Injection for Diabetic Macular Edema
by: Sentaro Kusuhara, et al.
Published: (2023-03-01)

Rationale and Design of VOYAGER: Long-term Outcomes of Faricimab and Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Clinical Practice
by: Robyn Guymer, MBBS, PhD, et al.
Published: (2024-05-01)

Treatment before macular grid in patients of diabetic macular edema
by: P S Srilatha, et al.
Published: (2018-01-01)

Two cases of diabetic macular edema with diminished areas of retinal non-perfusion and microaneurysms after intravitreal faricimab injections
by: Miki Sawa, et al.
Published: (2024-03-01)

Initial Real-World Experience with Faricimab in Treatment-Resistant Neovascular Age-Related Macular Degeneration
by: Leung EH, et al.
Published: (2023-05-01)

One-Year Outcomes of Faricimab Treatment for Aflibercept-Resistant Neovascular Age-Related Macular Degeneration
by: Rush RB
Published: (2023-08-01)

A Multicenter, Cross-Sectional Study of the Incidence of Major Macular Diseases That Cause Visual Impairment and Require Therapeutic Intervention in Greece: The ADVICE Study
by: Karagiannis DA, et al.
Published: (2020-05-01)

Faricimab for Diabetic Macular Edema in Patients Refractory to Ranibizumab or Aflibercept
by: Hiromi Ohara, et al.
Published: (2023-06-01)

Functional results one-year following the anti-VEGF therapy in macular pathology
by: Nicoleta Anton, et al.
Published: (2023-12-01)

Dexamethasone Intravitreal Implant for the Treatment of Macular Edema and Uveitis: A Comprehensive Narrative Review
by: Kishore K, et al.
Published: (2022-04-01)

Visual and anatomic outcomes of sustained single agent anti-VEGF treatment versus double anti-VEGF switching in the treatment of persistent diabetic macular edema
by: Osama A. Sorour, et al.
Published: (2020-06-01)

Survey of Intravitreal Injection Preferences for the Treatment of Age-Related Macular Degeneration and Macular Edema Among Members of the Turkish Ophthalmological Association
by: V. Levent Karabaş, et al.
Published: (2022-06-01)

Profile of patients receiving intravitreal anti-vascular endothelial growth factor injections during COVID-19-related lockdown
by: Manavi D Sindal, et al.
Published: (2021-01-01)

Burden Of Treatment Among Patients Undergoing Intravitreal Injections For Diabetic Macular Oedema In Australia
by: Spooner KL, et al.
Published: (2019-09-01)

Full-thickness macular hole formation following antivascular endothelial growth factor injection in a case of hemicentral retinal vein occlusion
by: Srijita Mitra, et al.
Published: (2021-01-01)

Short-Term Outcomes of Faricimab Treatment in Aflibercept-Refractory Eyes with Neovascular Age-Related Macular Degeneration
by: Maya Kishi, et al.
Published: (2023-08-01)